Revolutionizing stem cell therapies with iPSC -engineered MSCS
Technology Networks - 30-Apr-2025Cymerus™ platform enables scalable, donor-free MSC therapies for conditions like osteoarthritis
Join the club for FREE to access the whole archive and other member benefits.
Senior Science Writer at Technology Networks
Blake Forman is a Senior Science Writer at Technology Networks, where he covers breaking news and in-depth features across a wide range of scientific fields, with a particular focus on drug discovery and biopharma. He holds an honors degree in chemistry from the University of Surrey, which included a placement at the MHRA laboratory developing pharmaceutical testing methods, and an MSc in chemistry from the University of Southampton, where he researched novel fluorescent dyes for use in chemical sensing and photodynamic therapy. Before joining Technology Networks in 2024, Blake gained experience in several editorial roles within the science communication space.
Visit website: https://www.technologynetworks.com/biopharma/editor/blake-forman
See alsoDetails last updated 15-Jul-2025
Cymerus™ platform enables scalable, donor-free MSC therapies for conditions like osteoarthritis